Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12012381 Dimethyltryptamine analogues as nitric oxide delivery drugs

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Glenn Short0

Robert B. Perni0

Tanweer A. Khan0

Date of Patent

June 18, 2024

0

Patent Application Number

181474990

Date Filed

December 28, 2022

0

Patent Citations

US Patent 9720005 Immunoassay for compounds of the NBOMe family

0

US Patent 11242318 Deuterated tryptamine derivatives and methods of use

0

US Patent 11602521 N,N-dimethyltryptamine compositions and methods

0

US Patent 11332441 Crystalline N-methyl tryptamine derivatives

0

US Patent 11643391 Prodrugs and conjugates of dimethyltryptamine

0

US Patent 8268856 Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter

0

US Patent 9388395 Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs

0

Patent Primary Examiner

Daniel R Carcanague

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12012381 Dimethyltryptamine analogues as nitric oxide delivery drugs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool